General Information of the Compound
| Compound ID |
CP0422196
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-3-amino-N-(3-(2,4-dichlorophenyl)-1-(4-(1-((2-(4-methoxyphenyl)acetamido)methyl)cyclohexyl)piperazin-1-yl)-1-oxopropan-2-yl)propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H43Cl2N5O4
|
||||||||||||||||||
| Molecular Weight |
632.633
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(CC(=O)NCC2(CCCCC2)N2CCN(CC2)C(=O)[C@@H](Cc2ccc(Cl)cc2Cl)NC(=O)CCN)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H43Cl2N5O4/c1-43-26-9-5-23(6-10-26)19-30(41)36-22-32(12-3-2-4-13-32)39-17-15-38(16-18-39)31(42)28(37-29(40)11-14-35)20-24-7-8-25(33)21-27(24)34/h5-10,21,28H,2-4,11-20,22,35H2,1H3,(H,36,41)(H,37,40)/t28-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SDXNKLFMLKIOBP-MUUNZHRXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01325, Melanocortin receptor 3
Protein ID: PT00914, Melanocortin receptor 4
Protein ID: PT01804, Melanocortin receptor 5
Protein ID: PT00911, Melanocyte-stimulating hormone receptor